Product Information
NORTRIPTYLINE 10 MG/5 ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.2616 per ML under NDC 00121067816. Its NADAC has been published 339 times since Mar 18, 2015.
FDA first approved this application on Aug 23, 2000. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121067816
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075606FDA Approved
8/23/2000
TE Code
AA
On Market Since
8/23/2000
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE 10 MG/5 ML SOLN has been published 339 times since Mar 18, 2015, and over the history we have for it it has risen 26.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2616 per ML |
|---|---|
| All-time high | $0.3494 (May 15, 2024) |
| All-time low | $0.2072 (Mar 18, 2015) |
| 52-week high | $0.2753 |
| 52-week low | $0.2599 |
| Median price | $0.2863 |
| Average price | $0.2869 |
| Largest weekly change | +35.9% (May 22, 2019) |
| Weeks tracked | 339 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nortriptyline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE 10 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE 10 MG/5 ML SOLN, manufactured by PAI Holdings LLC, is $0.2616 per ML (NDC 00121067816), effective Sep 30, 2026.
How has the price of NORTRIPTYLINE 10 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE 10 MG/5 ML SOLN has risen 26.3%. It has been tracked across 339 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE 10 MG/5 ML SOLN?
Since Mar 18, 2015, the NADAC for NORTRIPTYLINE 10 MG/5 ML SOLN has ranged from a low of $0.2072 (Mar 18, 2015) to a high of $0.3494 (May 15, 2024), with a median of $0.2863 per ML.
Are there cheaper alternatives to NORTRIPTYLINE 10 MG/5 ML SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NORTRIPTYLINE 10 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures NORTRIPTYLINE 10 MG/5 ML SOLN?
NORTRIPTYLINE 10 MG/5 ML SOLN (NDC 00121067816) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.